Glaukos Corp. 10-K Annual Report covering 2022 ending 12/31/22 delivered to the SEC on February 24, 2023.See filing at: https://tinyurl.com/2ozzx2r9Critical Accounting Policies and Significant EstimatesManagement’s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles…
Glaukos Corp. with UV Corneal Drug Activation Delivers 10-K Annual Report to the SEC
More from InformationalMore posts in Informational »
- Misleading Readings: Pitfalls in UV Radiometry
- Multi-spectral Analysis Discovers Another Joan Miro Painting Underneath Known One
- Portage Suberb Of Chicago Updating UV Equipment At Water Treatment Plant
- Numerous Snake Species Emit UV Wavelengths For Species Interaction
- Guyana Water Purification Initiative Includes Use Of UV Irradiation And Science Education On Its Operational Principles